A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
Condition: Hypercholesterolemia Interventions: Drug: K-877 0.2 mg/day (once daily); Drug: K-877 0.4 mg/day (once daily); Drug: Placebo (once daily) Sponsor: Kowa Company, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Conditions: Primary Sclerosing Cholangitis; Inflammatory Bowel Diseases Intervention: Drug: Rosuvastatin Sponsor: Stanford University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials